Mecolzine

Mesalazine, the active ingredient in Mecolzine, is an aminosalicylate presented as an oral formulation for oral use. It is employed to reduce intestinal inflammation in ulcerative colitis and mild Crohn's disease, primarily in adult patients requiring localized anti‑inflammatory therapy.

GNH USA supplies Mecolzine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Customers benefit from consistent batch release, comprehensive documentation, and responsive technical support.

Mecolzine is an aminosalicylate that acts locally on the intestinal mucosa to control inflammatory bowel disease.

- Ulcerative colitis: reduces mucosal inflammation and helps maintain remission. - Mild Crohn's disease: alleviates intestinal inflammation in patients with limited disease activity. - Indeterminate colitis: provides anti‑inflammatory effect when the exact IBD subtype is not defined.

Mecolzine may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Headache: transient cranial discomfort. - Abdominal pain: cramping or discomfort in the abdomen. - Rash: skin irritation or mild erythema.

Serious or Rare Side Effects: - Myocarditis: inflammation of the heart muscle. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Blood dyscrasias: including neutropenia or agranulocytosis. - Pancreatitis: inflammation of the pancreas. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Interstitial nephritis: kidney inflammation that may affect function.

Before initiating therapy, clinicians should consider several safety measures.

- Renal monitoring: assess kidney function periodically. - Hepatic monitoring: check liver enzymes during treatment. - Disease assessment: evaluate IBD activity before and during therapy. - Hypersensitivity: avoid in patients with known allergy to mesalazine or related compounds. - Pregnancy and lactation: safety is unknown; use only if benefits outweigh risks. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mesalazine can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Antacids: may reduce mesalazine absorption. - Sulfasalazine: increased risk of toxicity when combined. - Methotrexate: additive bone‑marrow suppression. - Warfarin: potential enhancement of anticoagulant effect.

Moderate Interactions (Monitor Closely): - NSAIDs: heightened gastrointestinal irritation. - Corticosteroids: increased infection risk. - Oral contraceptives: possible alteration of hormone levels.